SPY336.83-0.61 -0.18%
DIA279.42-0.62 -0.22%
IXIC11,042.50+30.27 0.27%

ImmuCell Q3 EPS $(0.07) Up From $(0.17) YoY, Sales $2.97M Up From $2.154M YoY

ImmuCell (NASDAQ:ICCC) reported quarterly losses of $(0.07) per share. This is a 58.82 percent increase over losses of $(0.17) per share from the same period last year. The company reported $2.97 million in sales this

Benzinga · -

ImmuCell (NASDAQ:ICCC) reported quarterly losses of $(0.07) per share. This is a 58.82 percent increase over losses of $(0.17) per share from the same period last year. The company reported $2.97 million in sales this quarter. This is a 37.88 percent increase over sales of $2.154 million the same period last year.